title: Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy.
abstract: Primary adhalin (or alpha-sarcoglycan) deficiency due to a defect of the adhalin gene localized on chromosome 17q21 causes an autosomal recessive myopathy. We evaluated 20 patients from 15 families (12 from Europe and three from North Africa) with a primary adhalin deficiency with two objectives: characterization of the clinical phenotype and analysis of the correlation with the level of adhalin expression and the type of gene mutation. Age at onset and severity of the myopathy were heterogeneous: six patients were wheel-chair bound before 15 years of age, whereas five other patients had mild disease with preserved ambulation in adulthood. The clinical pattern was similar in all the patients with symmetric characteristic involvement of trunk and limb muscles, calf hypertrophy, and absence of cardiac dysfunction. Immunofluorescence and immunoblot studies of muscle biopsy specimens showed a large variation in the expression of adhalin. The degree of adhalin deficiency was fairly correlated with the clinical severity. There were 15 different mutations (10 missense, five null). Double null mutations (three patients) were associated with severe myopathy, but in the other cases (null/missense and double missense) there was a large variation in the severity of the disease.
authors.affiliation: INSERM U 153, Institut de Myologie, Hôpital de la Salpêtrière, Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Eymard
authors.forename: N B
authors.initials: NB
authors.lastname: Romero
authors.forename: F
authors.initials: F
authors.lastname: Leturcq
authors.forename: F
authors.initials: F
authors.lastname: Piccolo
authors.forename: A
authors.initials: A
authors.lastname: Carrié
authors.forename: M
authors.initials: M
authors.lastname: Jeanpierre
authors.forename: H
authors.initials: H
authors.lastname: Collin
authors.forename: N
authors.initials: N
authors.lastname: Deburgrave
authors.forename: K
authors.initials: K
authors.lastname: Azibi
authors.forename: M
authors.initials: M
authors.lastname: Chaouch
authors.forename: L
authors.initials: L
authors.lastname: Merlini
authors.forename: C
authors.initials: C
authors.lastname: Thémar-Noël
authors.forename: I
authors.initials: I
authors.lastname: Penisson
authors.forename: M
authors.initials: M
authors.lastname: Mayer
authors.forename: O
authors.initials: O
authors.lastname: Tanguy
authors.forename: K P
authors.initials: KP
authors.lastname: Campbell
authors.forename: J C
authors.initials: JC
authors.lastname: Kaplan
authors.forename: F M
authors.initials: FM
authors.lastname: Tomé
authors.forename: M
authors.initials: M
authors.lastname: Fardeau
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003598:Cytoskeletal Proteins / Q000172:deficiency* / Q000235:genetics* / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D005796:Genes; D005808:Genes, Recessive; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D008297:Male; D008562:Membrane Glycoproteins / Q000172:deficiency* / Q000235:genetics* / Q000378:metabolism; D009132:Muscles / Q000473:pathology / Q000503:physiopathology; D009136:Muscular Dystrophies / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D009154:Mutation; D049031:Sarcoglycans
chemical_list: D003598:Cytoskeletal Proteins; D008562:Membrane Glycoproteins; D049031:Sarcoglycans